ArticleRheumatology advances in practice2026
Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort.
Joseph Nathan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.